Cardio-cerebral infarction in left MCA strokes: a case series and literature review
Elochukwu Ibekwe1, Hera A Kamdar2, Tamara Strohm2
1Department of Neurology and Neurocritical Care, The Ohio State University, 395 West 12th Avenue, 7th Floor, Columbus, OH, 43210, USA. ibek01@osumc.edu.
Insights
Cardio-Cerebral Infarction (CCI), a rare simultaneous heart attack and stroke, presents complex treatment challenges. Current management strategies are individualized due to a lack of clear guidelines and evidence, with poor patient outcomes observed.
Area of Science:
- Cardiology
- Neurology
- Critical Care Medicine
Background:
- Cardio-Cerebral Infarction (CCI) is a rare condition involving simultaneous acute ischemic stroke (AIS) and acute myocardial infarction (AMI).
- Optimal management of CCI is unclear, posing significant therapeutic challenges for clinicians.
- Timely intervention is crucial for both conditions to prevent irreversible damage.
Observation:
- Three cases of CCI involving left MCA (M1) occlusion, STEMI, and left ventricular apical thrombus are presented.
- Treatment discussions included fibrinolysis and mechanical thrombectomy (MT), but only one patient received alteplase, and none underwent MT.
- Percutaneous coronary intervention (PCI) was performed in one case; modified heparin and antiplatelet therapy were administered to others.
Findings:
- All three patients diagnosed with CCI ultimately deceased.
- Key challenges include optimizing reperfusion strategies for both brain and heart, differing thrombolytic dosages, and risks associated with anticoagulation/antiplatelet therapy.
- Use of thrombolytics in STEMI requires caution due to potential myocardial rupture risk.
Implications:
- The absence of high-quality evidence and clinical guidelines necessitates highly individualized treatment approaches for CCI.
- Further research is needed to establish best practices for managing this complex dual pathology.
- Improved understanding and guidelines could enhance outcomes for patients presenting with simultaneous stroke and myocardial infarction.
Abstract:
The objective of this manuscript is to describe the challenges of Cardio-Cerebral Infarction (CCI) treatment and to highlight the variable approaches in management. CCI is a rare clinical presentation of simultaneous acute ischemic stroke (AIS) and acute myocardial infarction (AMI) and poses a therapeutic challenge for practitioners. Each disease requires timely intervention to prevent irreversible damage; however, optimal management remains unclear. We describe three cases of CCI. All three patients presented with symptomatic left MCA (M1) occlusion, with ST elevation myocardial infarction (STEMI) and left ventricular apical thrombus. Fibrinolysis and mechanical thrombectomy (MT) were discussed in all cases, but only one patient received alteplase (0.9 mg/kg) and none underwent MT. Percutaneous intervention (PCI) was done in only one case. The two patients that did not receive thrombolysis were treated with modified therapeutic heparin (no bolus), and all received antiplatelet therapy. Ultimately, all three patients passed away. CCI poses a clinical challenge for physicians including (1) optimal strategies to enable swift mechanical reperfusion to both the brain and myocardium; (2) difference in dosage of thrombolytics for AIS versus AMI; (3) risk of symptomatic intracerebral hemorrhage following administration of anticoagulation and/or antiplatelet therapy; and (4) caution with use of thrombolytics in the setting of acute STEMI due to the risk of myocardial rupture. In the absence of high quality evidence and clinical guidelines, treatment of CCI is highly individualized.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology


